溴尿嘧啶
PCAF公司
化学
癌症研究
转录因子
表观遗传学
生物化学
生物
基因
作者
P. G. Humphreys,Paul Bamborough,Chun‐wa Chung,Peter D. Craggs,Laurie Gordon,Paola Grandi,Thomas G. Hayhow,Jameed Hussain,Katherine L. Jones,Matthew Lindon,Anne‐Marie Michon,Jessica F. Renaux,Colin J. Suckling,David F. Tough,Rab K. Prinjha
标识
DOI:10.1021/acs.jmedchem.6b01566
摘要
p300/CREB binding protein associated factor (PCAF/KAT2B) and general control nonderepressible 5 (GCN5/KAT2A) are multidomain proteins that have been implicated in retroviral infection, inflammation pathways, and cancer development. However, outside of viral replication, little is known about the dependence of these effects on the C-terminal bromodomain. Herein, we report GSK4027 as a chemical probe for the PCAF/GCN5 bromodomain, together with GSK4028 as an enantiomeric negative control. The probe was optimized from a weakly potent, nonselective pyridazinone hit to deliver high potency for the PCAF/GCN5 bromodomain, high solubility, cellular target engagement, and ≥18000-fold selectivity over the BET family, together with ≥70-fold selectivity over the wider bromodomain families.
科研通智能强力驱动
Strongly Powered by AbleSci AI